Is HRPMF or JNJ a better dividend investment in 2026?

HRPMF currently yields 56.98% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: HRPMF offers higher current income.

What is the dividend yield difference between HRPMF and JNJ?

HRPMF has a forward dividend yield of 56.98% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 53.62 percentage points.

Home › Compare › HRPMF vs JNJ

HRPMF vs JNJ: Dividend Comparison 2026

HRPMF yields 56.98% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HRPMF wins by $541.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

HRPMF

● Live price

56.98%

Share price

$3.51

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$561.2K

Annual income

$126,052.94

Full HRPMF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — HRPMF vs JNJ

📍 HRPMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HRPMF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HRPMF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HRPMF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HRPMF

Annual income on $10K today (after 15% tax)

$4,843.30/yr

After 10yr DRIP, annual income (after tax)

$107,145.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, HRPMF beats the other by $106,441.39/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HRPMF + JNJ for your $10,000?

HRPMF: 50%JNJ: 50%

100% JNJ50/50100% HRPMF

Portfolio after 10yr

$290.6K

Annual income

$63,440.36/yr

Blended yield

21.83%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HRPMF

No analyst data

Altman Z

-40.5

Piotroski

2/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HRPMF buys

JNJ buys

No recent congressional trades found for HRPMF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHRPMFJNJ

Forward yield	56.98% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$561.2K ✓	$20.0K
Annual income after 10y	$126,052.94 ✓	$827.78
Total dividends collected	$460.7K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: HRPMF vs JNJ ($10,000, DRIP)

Year	HRPMF Portfolio	HRPMF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$16,398	$5,698.01	$10,676	$355.77	+$5.7K → HRPMF
2	$26,278	$8,732.33	$11,407	$389.39	+$14.9K → HRPMF
3	$41,196	$13,078.29	$12,198	$426.53	+$29.0K → HRPMF
4	$63,241	$19,161.35	$13,056	$467.62	+$50.2K → HRPMF
5	$95,159	$27,490.76	$13,987	$513.12	+$81.2K → HRPMF
6	$140,479	$38,659.15	$14,998	$563.56	+$125.5K → HRPMF
7	$203,650	$53,337.34	$16,098	$619.52	+$187.6K → HRPMF
8	$290,169	$72,263.73	$17,295	$681.69	+$272.9K → HRPMF
9	$406,709	$96,228.48	$18,599	$750.82	+$388.1K → HRPMF
10	$561,232	$126,052.94	$20,022	$827.78	+$541.2K → HRPMF

HRPMF vs JNJ: Complete Analysis 2026

HRPMF — Stock

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD. The company was incorporated in 2008 and is based in Espoo, Finland.

Full HRPMF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this HRPMF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HRPMF vs SCHD HRPMF vs JEPI HRPMF vs O HRPMF vs KO HRPMF vs MAIN HRPMF vs ABBV HRPMF vs MRK HRPMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.